COVID-19 Resource Center

COVID-19 Resource Center

Perspective from Ziyad Al-Aly, MD, FASN
Source:

NIH. NIH builds large nationwide study population of tens of thousands to support research on long-term effects of COVID-19. https://www.nih.gov/news-events/news-releases/nih-builds-large-nationwide-study-population-tens-thousands-support-research-long-term-effects-covid-19. Accessed Sept. 15, 2021.

Disclosures: Collins and Gibbons report no relevant financial disclosures.
September 16, 2021
1 min read
Save

NIH allocates nearly $470 million for long COVID research

Perspective from Ziyad Al-Aly, MD, FASN
Source:

NIH. NIH builds large nationwide study population of tens of thousands to support research on long-term effects of COVID-19. https://www.nih.gov/news-events/news-releases/nih-builds-large-nationwide-study-population-tens-thousands-support-research-long-term-effects-covid-19. Accessed Sept. 15, 2021.

Disclosures: Collins and Gibbons report no relevant financial disclosures.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

The NIH has allocated nearly $470 million to fund large-scale national studies of long COVID that it said could involve tens of thousands of patients.

Long COVID has been linked to more than 200 symptoms and can affect adults and children.

Woman with flu
Source: Adobe Stock.

“We know some people have had their lives completely upended by the major long-term effects of COVID-19,” NIH Director Francis S. Collins, MD, PhD, said in a news release. “These studies will aim to determine the cause and find much needed answers to prevent this often-debilitating condition and help those who suffer move toward recovery.”

The NIH’s Researching COVID to Enhance Recovery Initiative, or RECOVER, which was launched to explore why some have prolonged COVID-19 symptoms, made the parent award for research to New York University Langone Health, which will distribute multiple subawards to more than100 researchers at more than 30 institutions, the NIH said.

The award to NYU Langone Health will support new studies of COVID-19 survivors, as well as long-running large cohort studies with an expansion of the current research focus. This combined population of existing cohorts, along with new ones — also known as a meta-cohort — will comprise the RECOVER cohort.

“This scientifically rigorous approach puts into place a collaborative and multidisciplinary research community inclusive of diverse research participants that are critical to informing the treatment and prevention of the long-term effects of COVID-19,” Gary H. Gibbons, MD, co-chair of the RECOVER Initiative and director of NIH’s National Heart, Lung, and Blood Institute, said in the release.

Data among the RECOVER cohort will include clinical information, laboratory tests, and analyses of participants in various stages of recovery from COVID-19, the NIH said. According to the news release, with immediate access to data, it is anticipated that researchers will be able to accelerate the timeline for this research.

Study cohorts will include adult, pregnant and pediatric populations. Patients will be enrolled during the acute and post-acute phases of SARS-CoV-2 infection. Studies will evaluate tissue pathology, analyze data from millions of electronic health records and use mobile health technologies.